In August 2024, SYLKE® raised a $5.5 million Series Seed at a $50 million pre-money valuation.
$5.50 Million Series Seed
Latest Articles
-
-
SYLKE® is now ISO 13485:2016–certified and MDSAP-audited
SYLKE® Adhesive Wound Closure is now ISO 13485:2016–certified and MDSAP-audited - supporting market access, pending regulatory approval, in the Uni...
-
$10.03 Million Series A
In March 2025, SYLKE® raised a $10.03 million Series A at a $150 million pre-money valuation.
-
$5.50 Million Series Seed
In August 2024, SYLKE® raised a $5.5 million Series Seed at a $50 million pre-money valuation.
